Physician profile
Avinash C Gupta
NPI 1265531487
$49,578.18
in general payments reported to CMS, 2019-2025
48 companies · $1,886 in 2025
The $1,886 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $9,588 · 2021: $2,361 · 2022: $2,223 · 2023: $2,132 · 2024: $3,869 · 2025: $1,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,238 · Travel and Lodging: $1,617 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,237.74 |
| Travel and Lodging | $1,617.27 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $24,744.66 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $9,314.46 | 2019-2024 | Xarelto |
| Cvrx, INC. | $2,171.40 | 2021-2025 | Barostim Neo System |
| Boston Scientific Corporation | $1,950.25 | 2019-2025 | Watchman Access System, Watchman Flx, General - Crm_crm |
| Novartis Pharmaceuticals Corporation | $1,434.28 | 2019-2025 | |
| Amgen INC. | $1,152.15 | 2019-2024 | Evenity, Prolia, Repatha |
| Astrazeneca Pharmaceuticals Lp | $1,033.88 | 2019-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $993.50 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $857.62 | 2019-2024 | Aveir, Merlin@Home, Jot Dx |
| Pfizer INC. | $778.28 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $721.33 | 2019-2025 | Jardiance |
| Corcept Therapeutics | $691.66 | 2024-2025 | Korlym |
| Novo Nordisk INC | $613.46 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Philips North America LLC | $500.70 | 2022-2025 | (5044) Mcot, Mcot, (5050) Extended Holter |
| Merck Sharp & Dohme LLC | $440.32 | 2020-2025 | Verquvo |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $220.27 | 2020-2021 | |
| Heartflow, INC. | $190.94 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $151.32 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $135.91 | 2019-2023 | Evkeeza |
| Edwards Lifesciences Corporation | $124.63 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Sanofi-Aventis U.S. LLC | $106.30 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $101.80 | 2019-2021 | |
| Sanofi Pasteur INC. | $101.20 | 2019-2023 | |
| Lexicon Pharmaceuticals, INC. | $98.09 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals, Ltd. | $92.30 | 2023 | Arcalyst |
| Radius Health, INC. | $85.14 | 2022-2023 | |
| Medicomp INC | $80.84 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $65.26 | 2025 | |
| Esperion Therapeutics, INC. | $63.39 | 2021-2022 | |
| Glaxosmithkline, LLC. | $56.53 | 2020-2025 | Shingrix, Arexvy |
| Digirad Health, INC | $55.27 | 2022 | |
| Daiichi Sankyo INC. | $51.56 | 2022-2024 | Injectafer |
| Chiesi USA, INC. | $45.18 | 2024-2025 | Juxtapid |
| Scpharmaceuticals INC. | $44.97 | 2024-2025 | |
| Abiomed | $35.34 | 2025 | |
| Gilead Sciences, INC. | $35.20 | 2019 | |
| Vital Connect, INC | $34.19 | 2025 | Vitalpatch Rtm |
| Alexion Pharmaceuticals, INC. | $30.02 | 2021 | |
| Preventice Services, LLC | $28.37 | 2021 | |
| Baxter Healthcare | $23.15 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Silk Road Medical, INC. | $20.23 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| G Medical Diagnostic Services, INC. | $17.41 | 2019 | |
| Amryt Pharma Holdings Ltd | $15.03 | 2022 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Lilly USA, LLC | $14.74 | 2025 | Zepbound |
| Alnylam Pharmaceuticals INC. | $14.39 | 2025 | Onpattro |
| Xeris Pharmaceuticals, INC. | $13.44 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.82 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avinash Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.